A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
for Acute Myeloid Leukemias
26 locations incl. Burbank
Sponsor: Syndax Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT06226571·Phase 1·Recruiting